News Opinion Editor's Corner TCTMD’s Top 10 Most Popular News and Features for 2016 Shelley Wood December 29, 2016
News Daily News Not Following NOAC Dosing Instructions Tied to Worse Clinical Outcomes Todd Neale December 12, 2016
News Daily News Patients With A-fib Still Have High Mortality Risk After Appropriate Anticoagulation Is Started Todd Neale December 05, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for November 2016 Shelley Wood November 30, 2016
News Daily News Avoid Simvastatin, Lovastatin in Dabigatran-Treated Patients, Analysis Suggests Todd Neale November 24, 2016
News Conference News AHA 2016 Dabigatran Reversal Agent’s Safety, Efficacy Affirmed With Updated Study Results Todd Neale November 15, 2016
Presentation TCT 2016 Chronic Oral Anticoagulants: Limitations, Use Recommendations, and Investigational Agents Presenter: Paul A. Gurbel, Christopher B. Granger October 30, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2016 Caitlin E. Cox October 29, 2016
News Daily News Oral Anticoagulation Use Common in PCI Patients, With Triple Therapy the Norm at Discharge Todd Neale October 18, 2016
News Daily News Addition of Biomarkers May Fine Tune Risk Stratification in Atrial Fibrillation Michael O'Riordan October 07, 2016
News Daily News Were Problems With the Point-of-Care Device Used in ROCKET AF Kept From the FDA? BMJ Says Yes Todd Neale September 28, 2016
News Daily News Low-Dose NOACs Top Warfarin in Asian Patients in Everyday Practice, Retrospective Study Suggests Todd Neale September 26, 2016
News Daily News Amid Sparse Data on Infection After ASD Closure, Experts Urge Focus on Dental Health Yael L. Maxwell September 26, 2016
News Daily News Las Dosis Bajas de Superan a la Warfarina en Pacientes Asiáticos en la Práctica Rutinaria, según un Estudio Retrospectivo Todd Neale September 26, 2016
News Conference News ESC 2016 Reversal Agent for Factor Xa Inhibitors Rapidly Reduces Anticoagulant Effects: ANNEXA-4 Todd Neale August 31, 2016
News Conference News ESC 2016 NOACs as Effective as Warfarin for Reducing Stroke, but Apixaban and Dabigatran May Carry Lower Bleeding Risk: Registry Michael O'Riordan August 28, 2016
News Daily News Drug Company Payments to Physicians May Be Influencing Prescribing Todd Neale August 23, 2016
News Daily News Warfarin Control Over Time Is Shaky Even in Those Who Are Initially Stable Todd Neale August 10, 2016
News Daily News ARISTOTLE Analysis: Don’t Shy Away From Standard Apixaban Dose in Certain High-Risk Patients Todd Neale July 29, 2016